期刊文献+

糖尿病下肢血管成形术后患者对比剂肾病的危险性 被引量:3

Risk of Contrast Induced Nephropathy in Diabetic Patients with Lower Extremity Arterial Disease Undergoing Percutaneous Transluminal Angioplasty
在线阅读 下载PDF
导出
摘要 【目的】分析下肢动脉造影和经皮腔内血管成形术后患者对比剂肾病的发生率和相关危险因素,探讨糖尿病下肢动脉病变患者接受此项检查和治疗的肾安全性。【方法】2010年2月至2010年7月在中国中医科学院西苑医院血管外科行下肢动脉造影检查或/和腔内血管成形术治疗的连续性病例141例,分为糖尿病(n=91)和非糖尿病(n=50)组。记录患者一般资料及术中对比剂用量,测定术前血红蛋白浓度、血糖、血脂谱和血肌酐水平以及术后48 h血肌酐水平。采用独立样本t检验、卡方检验和多因素logistic回归模型进行统计分析。【结果】糖尿病组患者比非糖尿病组患者年龄大[分别为(71±9)和(63±17)岁,P=0.003]、血红蛋白浓度低[分别为(124±20)和(134±25)g/L,P=0.016]。在糖尿病组,基线肾功能减退亚组患者的对比剂用量比肾功能正常亚组少[分别为(48±15)和(57±18)mL,P=0.039)]。糖尿病组患者对比剂肾病的发生率与非糖尿病组患者相比无统计学差异(分别为7.7%和2.0%,P=0.260)。Logistic回归分析表明:血红蛋白浓度是对比剂肾病发生的独立危险因素(B=-0.075,OR=0.928,95%CI为0.868~0.991,P=0.026)。【结论】采用有效预防措施、控制对比剂用量,可能降低糖尿病患者下肢动脉造影和经皮腔内血管成形术后对比剂肾病发生的危险。糖尿病患者血红蛋白浓度降低,后者是对比剂肾病发生的独立危险因素,应该予以纠正。 【Objective】 To investigate the incidence of and risk predictive factors for contrast induced nephropathy(CIN) following lower extremity percutaneous transluminal angioplasty(PTA),and to evaluate the renal safety of this examination or treatment in diabetic patients with lower extremity arterial disease.【Methods】 From February to July in 2010,141 consecutive patients who underwent lower extremity PTA were analyzed retrospectively.All patients were divided into diabetic group(n = 91) or non-diabetic group(n=50).Demographic characteristics and the total volume of injected contrast medium were recorded.Baseline characteristics including the levels of hemoglobin,fasting plasma glucose,lipid profile,serum creatinine,as well as the serum creatinine level at 48 h after angioplastic procedure were measured.Independent t-test,chi-squre test and logistic regression model were applied.【Results】 The age was higher in diabetic group than that in non-diabetic group [(71 ± 9) vs(63 ± 17) years,P = 0.003],while the hemoglobin level was lower in diabetic group than that in non-diabetic group [(124 ± 20) vs(134 ± 25) g/L,P = 0.016].In diabetic patients,the volume of contrast medium was lower in the subgroup of impaired renal function than that in the normal renal function group [(48 ± 15) vs(57 ± 18) mL,P = 0.039].The incidence of CIN was no significant difference between diabetic and non-diabetic groups(7.7% vs 2.0%,P = 0.260).Logistic regression demonstrated that hemoglobin level was an independent predictor of CIN(B =-0.075,OR = 0.928,95%CI: 0.868 ~ 0.991,P = 0.026).【Conclusions】 Taking effective prophylaxis and restricting contrast medium volume,may reduce the risk of CIN in diabetic patients after angioplastic procedure.Decreased hemoglobin level,an independent predictor of CIN,has been shown in diabetic patients,and should be corrected.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2011年第5期659-663,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省自然科学基金重点资助项目(10251008901000010)
关键词 对比剂肾病 糖尿病 下肢动脉造影 经皮腔内血管成形术 contrast induced nephropathy diabetes percutaneous transluminal angioplaty
作者简介 刘丹,博士,主治医师,研究方向:糖尿病外周血管病变,E-mail:danliu66@gmail.com; 通信作者:严励,教授,研究方向:糖尿病慢性并发症,E-mail:hfxyl@163.net
  • 相关文献

二级参考文献26

  • 1Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
  • 2Parfrey E The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol 2005; 28 Suppl 2:S3-Sll.
  • 3Nozue T, Michishita I, Iwaki T, Mizuguchi I, Miura M. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol 2009; 54: 214-220.
  • 4Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006; (100): S 11-S 15.
  • 5Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
  • 6Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004; 183: 1673-1689.
  • 7Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary interventions. Circulation 2002; 105: 2259-2264.
  • 8Rahman MM, Haque HS, Banerjee SK, Ahsan SA, Rahman MF, Mahmood M, et al. Contrast induced nephropathy in diabetic and non-diabetic patients during coronary angiogram and angioplasty. Mymensingh Med J 2010; 19: 372-376.
  • 9Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. Can MedAssoc J 2005; 172: 1461-1471.
  • 10Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coil Cardiol 2004; 44: 1393-1399.

共引文献11

同被引文献47

  • 1Sketch MH Jr,Whelton A,Schollmayer E. Prevention of contrast media-induced renal dysfunction with prostaglandin E1:a randomized,double-blind,placebo-controlled study[J].American Journal of Therapeutics,2001.155-162.
  • 2Sudarsky D,Nikolsky E. Contrast-induced nephropathy in interventional cardiology[J].Int J Nephrol Renovasc Dis,2011.85-99.
  • 3Albert KG,Zimmet PZ. Definition, diagnosis and classification of diabetes mel itus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabetic Medicine,1998.539-553.
  • 4Thomsen HS. Guidelines for contrast media from the Europea Society of Urogenital Radiology[J].AMERICAN JOURNAL OF ROENTGENOLOGY,2003.1463-1471.
  • 5Cigarroa RG,Lange RA,Williams RH. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease[J].American Journal of Medicine,1989.649-652.
  • 6Kolonko A,Kokot F,Wiecek A. Contrast-associated nephropathy-old clinical problem and new therapeutic perspectives[J].Nephrology Dialysis Transplantation,1998.803-806.
  • 7Hardiek KJ,Katholi RE,Robbs RS. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography[J].Journal of Diabetes and its Complications,2008.171-177.
  • 8Chong E,Poh KK,Shen L. Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention[J].Singapore Medical Journal,2009.250-254.
  • 9Stacul F,Adam A,Becker CR. Strategies to reduce the risk of contrast-induced nephropathy[J].American Journal of Cardiology,2006.59K-77K.
  • 10Mueller C,Buerkle G,Buettner HJ. Prevention of contrast media-associated nephropathy:randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty[J].Archives of Internal Medicine,2002.329-336.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部